Literature DB >> 15057670

Elevated ghrelin plasma levels in patients with polycystic ovary syndrome.

R Waśko1, H Komarowska, A Warenik-Szymankiewicz, J Sowiński.   

Abstract

Polycystic ovary syndrome is a common endocrine disorder in women. It is associated with hirsuitism, obesity, insulin resistance, abnormality in the growth hormone/insulin-like growth factor I (IGF-1) axis and polycystic ovaries. The etiology of PCOS has not been clarified. Ghrelin is an endogenous ligand of the growth hormone secretagogue receptor. It is mainly secreted by stomach cells but has also been shown to be present in hypothalamus, pituitary, pancreas and gonads. Ghrelin is a regulator of energy homeostasis and GH secretion. The influence of ghrelin on insulin secretion and gonadal function is known. Since ghrelin may play an important role in pathophysiology of PCOS, we studied ghrelin levels in a group of 52 women with PCOS and in 16 women in a control group. Plasma levels of insulin, total testosterone, SHBG, LH, and FSH were also measured. In conclusion, PCOS women have higher ghrelin levels than controls. Ghrelin negatively correlates with BMI and insulin levels in PCOS group. A relation between ghrelin and SHBG was observed. Our data suggest that ghrelin could be the possible link in PCOS etiology.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15057670     DOI: 10.1055/s-2004-814341

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  10 in total

1.  Effect of Treatment with Metformin on Omentin-1, Ghrelin and other Biochemical, Clinical Features in PCOS Patients.

Authors:  Mahmud Shaker; Zohair I Al Mashhadani; Atheer A Mehdi
Journal:  Oman Med J       Date:  2010-10

2.  Study of Omentin1 and Other Adipokines and Hormones in PCOS Patients.

Authors:  Atheer Mahde; Mahmud Shaker; Zohair Al-Mashhadani
Journal:  Oman Med J       Date:  2009-04

3.  Total ghrelin levels during acute insulin infusion in patients with polycystic ovary syndrome.

Authors:  D Micic; M Sumarac-Dumanovic; A Kendereski; G Cvijovic; S Zoric; D Pejkovic; J Micic; N Milic; C Dieguez; F F Casanueva
Journal:  J Endocrinol Invest       Date:  2007-11       Impact factor: 4.256

Review 4.  Low circulating ghrelin levels in women with polycystic ovary syndrome: a systematic review and meta-analysis.

Authors:  Tian Gao; Lang Wu; Fuhou Chang; Guifang Cao
Journal:  Endocr J       Date:  2015-11-26       Impact factor: 2.349

5.  Effects of ghrelin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome.

Authors:  A Fusco; A Bianchi; A Mancini; D Milardi; A Giampietro; V Cimino; T Porcelli; D Romualdi; M Guido; A Lanzone; A Pontecorvi; L De Marinis
Journal:  J Endocrinol Invest       Date:  2007-12       Impact factor: 4.256

6.  Serum ghrelin levels in patients with Behcet's disease.

Authors:  Ilker Erden; Haydar Uçak; Betül Demir; Demet Cicek; Selma Bakar Dertlioğlu; Suleyman Aydin; Savas Ozturk
Journal:  Postepy Dermatol Alergol       Date:  2016-12-02       Impact factor: 1.837

Review 7.  The Role of the Gastric Hormones Ghrelin and Nesfatin-1 in Reproduction.

Authors:  Martha A Schalla; Andreas Stengel
Journal:  Int J Mol Sci       Date:  2021-10-14       Impact factor: 5.923

8.  Endotrophin as a novel marker in PCOS and its relation with other adipokines and metabolic parameters: a pilot study.

Authors:  Gurhan Guney; Mine Islimye Taskin; Ozgur Baykan; Ertan Adali; Selin Gul Tezcan; Serkan Sarikaya; Cihan Kaya; Ezgi Tolu
Journal:  Ther Adv Endocrinol Metab       Date:  2021-10-08       Impact factor: 3.565

9.  Serum leptin and ghrelin levels in women with polycystic ovary syndrome: correlation with anthropometric, metabolic, and endocrine parameters.

Authors:  Shiva Houjeghani; Bahram Pourghassem Gargari; Laya Farzadi
Journal:  Int J Fertil Steril       Date:  2012-06-19

Review 10.  New Aspects of Corpus Luteum Regulation in Physiological and Pathological Conditions: Involvement of Adipokines and Neuropeptides.

Authors:  Ewa Mlyczyńska; Marta Kieżun; Patrycja Kurowska; Monika Dawid; Karolina Pich; Natalia Respekta; Mathilde Daudon; Edyta Rytelewska; Kamil Dobrzyń; Barbara Kamińska; Tadeusz Kamiński; Nina Smolińska; Joelle Dupont; Agnieszka Rak
Journal:  Cells       Date:  2022-03-10       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.